Kimberlee C Drapkin Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kimberlee C Drapkin.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kimberlee C Drapkin. Kimberlee C Drapkin is Chief Financial Officer in EPIX Pharmaceuticals, Inc. ($EPIX) and Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and CFO and Treasurer in Jounce Therapeutics, Inc. ($JNCE).
Latest Insider Trading Transactions of Kimberlee C Drapkin
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, EPIX, JNCE, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | A | 11.89 | 44,500 | 529,105 | 44,500 | |
| Feb 03 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Grant | A | 0.00 | 22,250 | 0 | 65,431 | 43.2 K to 65.4 K (+51.53 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 2.36 | 3,799 | 8,966 | 206,005 | |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 2.36 | 3,710 | 8,756 | 209,804 | |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 0.74 | 6,775 | 5,014 | 0 | |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 0.48 | 3,016 | 1,448 | 0 | |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 12.00 | 3,799 | 45,588 | 43,181 | 47 K to 43.2 K (-8.09 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 2.36 | 3,799 | 8,966 | 46,980 | 43.2 K to 47 K (+8.80 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 10.03 | 10,000 | 100,300 | 43,181 | 53.2 K to 43.2 K (-18.80 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 12.03 | 16,201 | 194,898 | 53,181 | 69.4 K to 53.2 K (-23.35 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 2.36 | 3,710 | 8,756 | 69,382 | 65.7 K to 69.4 K (+5.65 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 0.74 | 6,775 | 5,014 | 65,672 | 58.9 K to 65.7 K (+11.50 %) |
| Jan 22 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 0.48 | 3,016 | 1,448 | 58,897 | 55.9 K to 58.9 K (+5.40 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 7.00 | 3,130 | 21,910 | 55,881 | 59 K to 55.9 K (-5.30 %) |
| Jan 11 2021 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 6.76 | 2,697 | 18,232 | 59,011 | 61.7 K to 59 K (-4.37 %) |
| Sep 02 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 8.06 | 7,200 | 58,032 | 61,708 | 68.9 K to 61.7 K (-10.45 %) |
| Aug 18 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 4.71 | 744 | 3,504 | 68,908 | 69.7 K to 68.9 K (-1.07 %) |
| Aug 18 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 4.86 | 454 | 2,206 | 69,652 | 70.1 K to 69.7 K (-0.65 %) |
| Aug 18 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 4.64 | 984 | 4,566 | 70,106 | 71.1 K to 70.1 K (-1.38 %) |
| Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Drapkin Kimberlee C | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 | |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | A | 6.55 | 53,400 | 349,770 | 53,400 | |
| Feb 04 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Grant | A | 0.00 | 26,700 | 0 | 71,090 | 44.4 K to 71.1 K (+60.15 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 7.78 | 2,624 | 20,415 | 44,390 | 47 K to 44.4 K (-5.58 %) |
| Jan 10 2020 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 7.78 | 2,624 | 20,415 | 44,390 | 47 K to 44.4 K (-5.58 %) |
| Aug 16 2019 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 3.92 | 1,018 | 3,991 | 47,014 | 48 K to 47 K (-2.12 %) |
| Aug 16 2019 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 4.00 | 648 | 2,592 | 48,032 | 48.7 K to 48 K (-1.33 %) |
| Aug 16 2019 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 4.10 | 670 | 2,747 | 48,680 | 49.4 K to 48.7 K (-1.36 %) |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | A | 4.40 | 44,500 | 195,800 | 44,500 | |
| Feb 05 2019 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Grant | A | 0.00 | 22,250 | 0 | 49,350 | 27.1 K to 49.4 K (+82.10 %) |
| Feb 05 2019 | PTI | PROTEOSTASIS THERA ... | Drapkin Kimberlee C | Director | Option Exercise | A | 3.00 | 30,600 | 91,800 | 30,600 | |
| Aug 28 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 2.36 | 12,700 | 29,972 | 213,514 | |
| Aug 28 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 2.36 | 12,700 | 29,972 | 27,100 | 14.4 K to 27.1 K (+88.19 %) |
| Aug 15 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Grant | A | 0.00 | 14,400 | 0 | 14,400 | 0 to 14.4 K |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 0.48 | 3,759 | 1,804 | 3,016 | |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 25.01 | 5,267 | 131,728 | 0 | 5.3 K to 0 (-100.00 %) |
| Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 0.48 | 3,759 | 1,804 | 5,267 | 1.5 K to 5.3 K (+249.27 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 22.07 | 1,267 | 27,963 | 1,508 | 2.8 K to 1.5 K (-45.66 %) |
| Mar 07 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 21.21 | 4,000 | 84,840 | 2,775 | 6.8 K to 2.8 K (-59.04 %) |
| Feb 05 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | A | 23.98 | 97,500 | 2,338,050 | 97,500 | |
| Jul 01 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Payment of Exercise | F | 0.14 | 193,839 | 27,137 | 324,367 | 518.2 K to 324.4 K (-37.41 %) |
| Jul 01 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Grant | A | 0.00 | 464,285 | 0 | 518,206 | 53.9 K to 518.2 K (+861.05 %) |
| Mar 19 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 0.41 | 70,000 | 28,700 | 70,000 | |
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | M | 0.00 | 8,750 | 0 | 8,750 | |
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Payment of Exercise | F | 0.46 | 3,294 | 1,515 | 53,405 | 56.7 K to 53.4 K (-5.81 %) |
| Feb 26 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Buy | M | 0.00 | 8,750 | 0 | 56,699 | 47.9 K to 56.7 K (+18.25 %) |
| Jan 05 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Payment of Exercise | F | 1.03 | 26,157 | 26,942 | 47,949 | 74.1 K to 47.9 K (-35.30 %) |
| Jan 05 2009 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Grant | A | 0.00 | 63,106 | 0 | 74,106 | 11 K to 74.1 K (+573.69 %) |
| Feb 26 2008 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,500 | 0 | 17,500 | |
| Feb 26 2008 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 3.15 | 40,000 | 126,000 | 40,000 | |
| Feb 07 2007 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 6.50 | 7,236 | 47,034 | 7,236 | |
| Feb 07 2007 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 6.50 | 28,544 | 185,536 | 28,544 | |
| Nov 07 2006 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | M | 0.98 | 11,000 | 10,780 | 70,830 | |
| Nov 07 2006 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Buy | M | 0.98 | 11,000 | 10,780 | 11,000 | 0 to 11 K |
| Aug 21 2006 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 7.20 | 50,000 | 360,000 | 50,000 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 1.74 | 38,482 | 66,959 | 38,482 | |
| Aug 18 2006 | EPIX | EPIX Pharmaceutica ... | Drapkin Kimberlee C | Chief Financial Off ... | Option Exercise | A | 0.98 | 81,380 | 79,752 | 81,380 |
Page: 1